An integrative analysis of genetic factors reveals dysregulation of cytokines, immune signaling, and T cell activity as the underlying immune mechanisms in autoimmune immune thrombocytopenia

对遗传因素的综合分析揭示了细胞因子、免疫信号传导和T细胞活性的失调是自身免疫性血小板减少症的潜在免疫机制。

阅读:3

Abstract

BACKGROUND: Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immune-mediated platelet destruction, leading to an abnormally reduced platelet count. While numerous susceptibility genomic loci have been identified, the genetic mechanisms and pathways driving ITP remain poorly understood. This limits treatment options to broad immunosuppressants that increase patient vulnerability. OBJECTIVE: This study aims to uncover the functional and biological significance of ITP-associated genetic variations by integrating bioinformatics approaches. It seeks to identify functional SNPs, key immune pathways, and potential drug targets to enhance understanding of ITP pathogenesis and support the development of targeted therapies. METHODS: An integrative bioinformatics approach was employed to identify expression quantitative trait loci (eQTL) and pathogenic SNPs, reconstruct protein-protein interaction (PPI) networks, perform gene ontology analysis, and explore potential drug targets. RESULTS: The study identified 60 eQTL and 6 pathogenic SNPs associated with ITP, along with over 300 gene ontology processes. 14 hub genes in the PPI network were linked to key immune mechanisms, including T cell dysfunction (CD40, CTLA4, FOXP3, IL-10, IL-4, TBX21), cytokine dysregulation (IFNG, IL-6, IL-10, IL-4, TNF-α, TGFB1), JAK/STAT signaling (JAK2, STAT1, STAT3), and pattern-recognition (TLR4). TNF-α emerged as the top-ranked hub gene. Additionally, several platelet related genes (HPA2, MPL, PRKCA, PTPN11, and others) were implicated in the analysis. CONCLUSION: Functional SNPs and hub genes identified in this study serve as potential biomarkers for ITP diagnosis and prognosis. Cytokine pathways and T cell subsets were highlighted as central players in ITP pathogenesis. The drug-gene interaction analysis further suggests potential therapeutic avenues through drug repurposing, offering insights into novel treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12959-026-00833-0.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。